# Flumazenil


Competitive antagonist and inverse agonist of the benzodiazepine receptor.

|Property|Action|
|--|--|
|**Class**|Imidazo-benzodiazepine
|**Uses**|Reversal of BZD
|**Route of Administration**|IV
|**Dosing**|0.1mg boluses up to 2mg
|**Onset**|Within 2 minutes
|**Distribution**|Moderate lipid solubility, 50% protein bound. t~1/2~Î² < 1 hour - may require infusion.
|**Metabolism**|Hepatic to inactive metabolites
|**Elimination**|Renal of metabolites
|**CNS**|May precipitate seizures or BDZ withdrawal due to inverse agonist effect
|**GIT**|N/V


---

## References

1. Petkov V. Essential Pharmacology For The ANZCA Primary Examination. Vesselin Petkov. 2012.

